This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Markus Mandler, PhD
CSO at Accanis Biotech
Speaker

Profile

Dr. Mandler is CSO of ACCANIS, bringing with him over 10 years of collaborative research and management experience spanning academia and industry. He completed his PhD at Boehringer IngelheimĀ“s Institute of Molecular Pathology in Vienna in 2003. During his PhD, he worked on skin development and especially focused on appendages including hair, feathers, and teeth. Dr. Mandler is a former department head at AFFiRiS where he was responsible for developing 5 immunotherapeutics from preclinic into early clinical development. He has authored numerous publications in high impact journals, several patents and has received multiple national and international research grants for his work.

At this event

Prev
Next
Muthiah (Mano) Manoharan, PhD
Senior Vice President of Drug Discovery
Alnylam Pharmaceuticals, Inc.

See Markus at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub